header-logo
MSTP students in the Sahoo lab
Medical Scientist Training Program
Michael Lam

Michael Lam

G1 Student

Faculty Advisor

  • Jonathan Marchant, PhD, Cell Biology, Neurobiology & Anatomy

Locations

  • Medical Scientist Training Program

Contact Information

Education

BS, Molecular Cell Biology & Physiology, California State University-Long Beach, 2021

Research Interests

Structural biology, molecular modeling, genomic regulation, and neurodegenerative diseases

Research Experience

Medical College of Wisconsin, 2025-Present
Advisor: Jonathan Marchant, PhD

National Institute of Health, June 2021-August 2021
Advisor: Dr. Claire le Pichon
Project: ATF3 Expression Upregulated in Regenerating Motor Neurons Following Specific Nerve Injury

California State University-Long Beach (RISE Fellow), Sep 2017-May 2021
Advisor: Dr. Jason Schwans
Project: Fmoc-Dipeptides as a Scaffold to Systematically Investigate Inhibitors of Butyrylcholinesterase, an Enzyme Implicated in Alzheimer's Disease

California State University-Long Beach, Dec 2020-May 2021
Advisor: Kashima Samuels
Project: Addressing Attrition Rates Among UHP Students: A Retrospective Alumni Study

Publications

Stuttgen GM, Bobek JM, Penoske R, Wadding-Lee C, Lam M, Hader SN, Owens AP 3rd, Sahoo D. FFAR4 Deficiency Increases Necrotic Cores in Advanced Lesions of ApoE-/- Mice-Brief Report. Arterioscler Thromb Vasc Biol. 2025 May;45(5):675-682. doi: 10.1161/ATVBAHA.124.322371. Epub 2025 Mar 6. PMID: 40047073; PMCID: PMC12018153.

Meeting Abstracts

Characterizing injury marker expression in motor neurons after sciatic nerve trauma in mouse; National Institute of Health Summer Internship Poster Day 2021, Aug 2021. [Zoom poster]

Fmoc-Dipeptides as a Scaffold to Systematically Investigate Inhibitors of Butyrylcholinesterase, an Enzyme Implicated in Alzheimer's Disease; CSULB Honors' Program Thesis Presentations 2021, May 2021. [Zoom Oral Presentation]

Fmoc-Dipeptides as a Scaffold to Systematically Investigate Inhibitors of Butyrylcholinesterase, an Enzyme Implicated in Alzheimer's Disease. Annual Biomedical Research Conference 2019, Nov 2019. [poster]

Investigating the Role of Stereochemistry in the Development of Cholinesterase Inhibitors to Treat Alzheimer's Disease. CNSM Research Symposium at CSULB, Sep 2019. [Poster]

Investigating the Role of Stereochemistry in the Development of Cholinesterase Inhibitors to Treat Alzheimer's Disease. SoCal Undergraduate Research Symposium at UCI; Sep 2019. [Poster]

Investigating the Role of Stereochemistry in the Development of Cholinesterase Inhibitors to Treat Alzheimer's Disease. 2019 UROP Annual Research Symposium; May 2019. [Poster]

Investigating the Role of Stereochemistry in the Development of Cholinesterase Inhibitors to Treat Alzheimer's Disease. Southern California Undergraduate Research, Mar 2019. [Poster]

Comparative Study Evaluating Fmoc-Lys(Mtt)-OH as a Selective Inhibitor of Butyrylcholinesterase. 2018 UROP Annual Research Symposium. May 2018.

General Interests

Anime, gaming, gym, poetry, vlogging, fishing, and writing

© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.